Jun Tian
Peking Union Medical College
4 Papers
Jun Tian is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Cystectomy. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus
Chuanzhen Cao,Chuanzhen Cao,Xingang Bi,Jing Liang,Lin Li,Huijuan Zhang,Zhendong Xiao,Zejun Xiao,Jun Tian,Dong Wang,Kaopeng Guan,Changling Li,Jianhui Ma,Shan Zheng,Jianzhong Shou +14 more
TL;DR: After radical surgery, RCC patients with RVTT had a relatively fair prognosis except for patients with friable thrombus, PNS, higher modified Fuhrman grade and perirenal fat invasion.
Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer.
Linjun Hu,Qinxin Zhao,Hongsong Bai,Chengming Xie,Xingli Shan,Dehu Lu,Yonghai Chen,Dongdong Han,Zejun Xiao,Jun Tian,Dong Wang,Xingang Bi,Nianzeng Xing +12 more
TL;DR: ADT combined with 6 cycles of docetaxel + prednisone chemotherapy benefits patients diagnosed with high-burden mHSPC in terms of the OS, PFS of PSA and radiographic, and the ratio of PSC falling to 0.2 ng/mL.
Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study.
Hongzhe Shi,Wen Zhang,Xingang Bi,Dong Wang,Zejun Xiao,You-yan Guan,Kaopeng Guan,Jun Tian,Hongsong Bai,Linjun Hu,Chuanzhen Cao,Weixing Jiang,Zhilong Hu,Jin Zhang,Yan Chen,Shan Zheng,Xiao-Li Feng,Changling Li,Yexiong Li,Jianhui Ma,Yueping Liu,Aiping Zhou,Jianzhong Shou +22 more
TL;DR: In this article, the authors assessed real NAC efficacy without interference from TURBT and applied combined modality therapies guided by NAC for muscle-invasive bladder cancer (MIBC) patients.
Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma.
Xiangpeng Kang,Hongzhe Shi,Dong Wang,Zejun Xiao,Jun Tian,Xingang Bi,Weixing Jiang,Changling Li,Jianhui Ma,Shan Zheng,Yueping Sun,Jianzhong Shou +11 more
TL;DR: The FCN score combining peripheral blood indicators of inflammation and coagulation is an independent prognostic marker of ccRCC and the FCNTG model, which systemically incorporates preoperative blood indexes to oncological characteristics, shows its advantages of convenience and high prediction efficiency.